Atul share price today

Atul Ltd's share price was ₹5,028.50 at the close on 30 October 2026. It has been falling for 4 weeks. That is 20.4% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹5,029 and ₹7,100, and at that close it was at the low of that range.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Atul Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 2 weeks running.

Over the last 11 years the share price moved +270% while the NIFTY 500 moved +257%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 16 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: profit fell in the September 2026 quarter, revenue up on a year earlier for 11 quarters in a row and lowest operating margin in 10 quarters.

1. Profit fell in the September 2026 quarter

   Profit was ₹159 crore, -12.6% on a year earlier (₹182 crore), after 9 quarters of growth.

2. Revenue up on a year earlier for 11 quarters in a row

   In the September 2026 quarter revenue was ₹1,877 crore, +20.9% on a year earlier.

3. Lowest operating margin in 10 quarters

   Operating margin was 13% in the September 2026 quarter, against 17% a year earlier.

For July to September 2026 (the quarter ended 30 September 2026), Atul reported revenue of ₹1,877 crore, up 20.9% from ₹1,552 crore a year earlier, and a profit of ₹159 crore, down 12.6% from ₹182 crore.

Atul results: July to September 2026 against a year earlier

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

Atul closed at ₹5,028.50 on 30 October 2026, down 12.7% from ₹5,762.50 a year earlier (31 October 2025) and down 44.9% over five years. Its highest weekly close since February 2016 was ₹10,535.20 on 8 October 2021.

Atul share price: then and now

Weekly closing prices. Each change is the move from that price to the 30 Oct 2026 close. A day's intraday high or low can go beyond these weekly closes.

563 weekly closes from 26 February 2016 to 30 October 2026.

30 Oct 2026: Atul closed at ₹5,028.50, down 9.8% on the week and down 14.2% on the month. Results for July to September 2026: Revenue up 20.9% and profit down 12.6% on a year earlier.

Earlier

• 17 Jul 2026: ex-date for a dividend of ₹30 a share.
• Our read, 17 May 2026: FY24-cycle trough is confirmed behind, a depressed-base specialty chemicals compounder turning the corner on volumes, margins, and new product cadence.

Our read of the business

₹1,200 Cr surplus funds + near-zero debt = capital spending optionality preserved.

Latest quarter: Record quarterly sales, but profit boosted by ₹90 Cr other income and provision reversal.

Our read after the latest results, written 17 May 2026.

Atul paid ₹30 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.60% at the ₹5,028.50 close on 30 October 2026. The last was a dividend of ₹30 a share, ex-date 17 July 2026.

Atul dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date.

Yes. Atul Ltd paid out 13% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years.

From the NSE corporate-actions record, read 5 November 2026.

Atul's management made 0 promises we could check against what it later reported.

Our read after the latest results, written 17 May 2026.

What is changing at Atul, from the latest results and calls: specialty chemicals destocking cycle end, volume recovery, life science chemicals, margin premium + export growth (2,4-d, indoxacarb, sulphonyl urea) and liquid epoxy resin (ler) facility ramp, new capacity driving performance chemicals.

• Specialty Chemicals Destocking Cycle End, Volume Recovery. Revenue grew 7 consecutive quarters through FY26, with 4 consecutive quarters of on a year earlier profit acceleration, the global agro-chemical and specialty chemicals destocking cycle that cratered FY24 earnings is definitively over. ⚠ estimate
• Life Science Chemicals, Margin Premium + Export Growth (2,4-D, Indoxacarb, Sulphonyl Urea). Life Science segment runs 19% PBIT margins vs 10% for Performance Chemicals, growing crop protection export volumes (2,4-D, Indoxacarb, Sulphonyl Urea herbicides/insecticides) improve the revenue mix and lift blended margins structurally. ⚠ estimate
• Liquid Epoxy Resin (LER) Facility Ramp, New Capacity Driving Performance Chemicals. The recently commissioned LER plant drove July to September 2025 domestic volume uplift, higher LER volumes from new facility was explicitly cited as the key Q2 on a year earlier revenue driver in the company presentation. ⚠ estimate
• New Product Launches, Crop Protection Retail + Water Treatment JV. Three new crop protection products (Mylonis, Salix Gold, Tikadis, May 2026) goal India's ₹25,000 Cr+ crop protection market; Atul-Buckman water treatment JV (Feb 2026) opens a new segment. ⚠ estimate

We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown.

Our read after the latest results, written 17 May 2026.

China remains the structural headwind, if export pricing aggression resumes (driven by domestic oversupply or policy shifts), Atul's agro-chemical and dye segments face margin re-compression similar to FY24.

The main risks

• Chinese Specialty Chemicals Competition Resumes Aggression: China remains the structural headwind, if export pricing aggression resumes (driven by domestic oversupply or policy shifts), Atul's agro-chemical and dye segments face margin re-compression similar to FY24. ⚠ estimate
• Other Income Dependency, Q4 profit Quality Concern: January to March 2026 profit of ₹210 Cr included ₹90 Cr other income (31.9% of PBDIT) and a ₹24 Cr employee provision reversal, strip these out and core profit is ~₹96 Cr, implying profit quality significantly weaker than headline. ⚠ estimate
• Agro-Chemical Demand Cyclicality, Monsoon Sensitivity: Crop Protection is both Life Science's largest driver and inherently cyclical, a poor FY27 monsoon, farm income stress, or channel restocking pause can abruptly reverse the recovery. ✓ fact
• Input Cost Volatility, Benzene, Toluene, Petrochemical Feedstocks: Atul uses benzene, toluene, and other crude-linked petrochemical feedstocks as raw materials, an oil price spike compresses margins; current recovery partially aided by favorable feedstock costs. ⚠ estimate

Our read after the latest results, written 17 May 2026.

When Atul reports October to December 2026, these are the 5 checks that show whether the story is still on course. First: Chinese benzene/agrochemical export price indices; Atul's quarterly operating margin trend vs prior year.

Atul is on 3 of our India lists: Undervalued stocks, 52 week high & low and Small & mid cap stocks.

Atul Ltd earned ₹159 Cr of net profit in the Sep 2026 quarter, −12.6% on the same quarter a year earlier. Full-year FY26 profit was ₹689 Cr. Over 10 years profit has grown 9.7% a year on average. That is 8.5% of the quarter's revenue. The same quarter a year earlier earned ₹182 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹689 Cr (+38.1% on the year before).

Why profit moved: revenue changed +20.9% on a year earlier and the margin moved −4.0 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed +45.6% and revenue +18.0%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

Atul Ltd reported ₹1,877 Cr of revenue in the Sep 2026 quarter, +20.9% on the same quarter a year earlier. That is the 11th quarter in a row with growth on the year before. Over 10 years it has grown 9.2% a year on average. The last full year, FY26, came in at ₹6,274 Cr.

Revenue is everything the company billed its customers in the period.

Why this happened. As confirmed in the Q2 FY26 company presentation: 'The Company maintains a strong Balance Sheet with ~₹1,200 cr of surplus funds available for future expansion.' Net D/E of -0.18 (net cash). Current funds of ₹1,159 Cr as at Sep 30, 2025. This is both a quality floor (no financial risk) and a potential catalyst if capex is announced with a clear returns thesis.

The last four reported quarters add to ₹6,969 Cr.

FY26 revenue was ₹6,274 Cr, +12.4% on the year before.

Recent pace: the last four quarters grew +18.0% on average, against 9.2% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +18.1%, against +17.3% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +40.5%, against +43.4% a year (stabilising).

Atul Ltd's operating margin was 13.0% in the Sep 2026 quarter, 4.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 14.0% and 25.0%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why this happened. H1 FY26 segment data from the official company presentation shows Life Science Chemicals PBIT% at 19% versus Performance & Other Chemicals at 10%. Export-led growth in Crop Protection, Bulk Actives (2,4-D herbicide, Indoxacarb insecticide, Sulphonyl Urea) drove the Life Science segment 7% YoY in H1, with export realizations recovering. If Life Science grows faster than Performance Chemicals, the blended EBITDA margin will expand even without volume growth in the lower-margin segment.

Why the margin moved: operating margin changed −4.1 percentage points on the year while gross margin changed −6.6 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 152% of Atul Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹1,023 Cr of operating cash against ₹689 Cr of profit. After ₹137 Cr of spending on assets, ₹886 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 152% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle.

What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets.

Atul Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 70 days in FY26, down from 78 days in FY21. It spent ₹865 Cr on assets over the last 3 years. Customers take 74 days to pay, and stock sits for 90 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹6,274 Cr, each day of that cycle ties up about ₹17.2 Cr, so roughly ₹1,203 Cr is tied up in the business at any time.

FY26: customers took 74 days to pay and stock sat for 90 days, about 3.0 months of sales sitting as stock, for a full cycle of 70 days, shorter than FY21's 78.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 90 days. Customers pay about 74 days after that. Suppliers are paid at 94 days. Together that makes the 70-day cycle.

Spending on assets: ₹865 Cr over the last 3 years, against ₹882 Cr of depreciation (the yearly wear and tear on existing assets). So it is spending about what it takes to replace what wears out, or less. Work still in progress is ₹110 Cr (FY26): assets paid for that are not earning yet.

In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean.

Atul Ltd's P/E is 19.2×, near the low end of its own history: it has been lower only 3% of the time. Its usual P/E (the middle reading) is 32.6×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.